Craig Nash
About Craig Nash
Craig Nash is a Senior Research Scientist I at the Broad Institute of MIT and Harvard, specializing in cardiovascular disease research. He has extensive experience in confocal microscopy and cell signaling analysis, with a background that includes positions at several prestigious institutions.
Work at Broad Institute
Craig Nash currently holds the position of Senior Research Scientist I within the Cardiovascular Disease Initiative at the Broad Institute of MIT and Harvard. He has been with the organization since 2022, contributing to research efforts in Cambridge, Massachusetts. Prior to his current role, he served as Research Scientist II in the same initiative from 2020 to 2022. His work focuses on advancing understanding in cardiovascular diseases through innovative research methodologies.
Education and Expertise
Craig Nash earned his Bachelor’s Degree in Biochemistry from The University of Birmingham, where he studied from 2005 to 2008. He continued his education at the same institution, obtaining a Doctor of Philosophy (PhD) in Cardiovascular Science from 2008 to 2011. His expertise includes confocal microscopy with second messenger biosensors, phosphorylation analysis related to cell signaling by GPCRs and kinases, and primary cell isolation combined with second messenger biochemistry.
Professional Background
Craig Nash has a diverse professional background in cardiovascular research. He began his career as a Postdoctoral Research Associate at the University of Leicester from 2012 to 2014. Following this, he worked as a Postdoctoral Associate at the University of Rochester for one year, from 2015 to 2016. He then served as a Research Investigator at the University of Michigan from 2016 to 2019, before joining the Broad Institute.
Research Contributions
Throughout his career, Craig Nash has contributed to various research projects focused on cardiovascular diseases. His work has involved advanced techniques in cell signaling and biochemistry, particularly in relation to GPCRs and kinases. His research aims to enhance the understanding of cardiovascular conditions and improve therapeutic approaches.